Skip to content
MMJ Gazette
  Tuesday 26 August 2025
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
  • Home
  • News
  • CBD
  • Cannabis
  • Drugs
  • Marijuana
  • Tobacco
  • Law
Trending
August 23, 2025South Dakota Marijuana Industry Rallies Behind Crackdown on Hemp THC August 22, 2025Florida Court Says Medical Marijuana Patients Can Own Guns August 7, 2025Los Angeles Greenlighted Massive Fee Hikes for Cannabis Operators—And Businesses Say It Could Break Them August 6, 2025Ayr Wellness to Shutter Grow Sites in Massachusetts and Nevada Amid Financial Strain August 4, 2025Cannabis Businesses Face Tightrope Act as Rules Shift State to State August 3, 2025Cannabis Dispensaries Rethink Retail: Design That Sells, Not Just Serves August 2, 2025Legal Weed’s Tax Nightmare: How Cannabis Firms Are Pushing Back Against 280E August 2, 2025Kentucky Gears Up for First Legal Medical Marijuana Sales by Autumn July 31, 2025Hemp THC Ban Pulled from Senate Bill After McConnell–Paul Face-Off July 30, 2025Oklahoma’s Marijuana Legalisation Fight Is Back—And It’s Getting Personal
MMJ Gazette
MMJ Gazette
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
MMJ Gazette
  Health  Pioneering Sleep: The Dawn of Fast-Absorption CBD Tablets
HealthNews

Pioneering Sleep: The Dawn of Fast-Absorption CBD Tablets

Lars BeckersLars Beckers—April 4, 20240
FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

The pharmaceutical landscape is witnessing a revolutionary stride with the introduction of a new, fast-absorbing CBD tablet aimed at treating insomnia. This innovation emerges from a strategic collaboration between dsm-firmenich and OMG Pharma, marking a significant leap in patient-centric healthcare.

Orally dispersible tablets are set to transform the way CBD is administered, offering a swift and efficient method of drug delivery. These tablets dissolve under the tongue, bypassing the digestive system and ensuring rapid absorption into the bloodstream.

 CBD Tablets

The Science Behind the Breakthrough

The collaboration leverages dsm-firmenich’s expertise in high-quality GMP CBD active pharmaceutical ingredients and advanced formulation capabilities. The focus is on enhancing bioavailability, a critical factor in ensuring the medication’s effectiveness.

OMG Pharma’s dedication to innovative cannabinoid medicine research complements dsm-firmenich’s mission to deliver solutions that address unmet patient needs. Together, they aim to introduce the world’s first regulatory-approved over-the-counter CBD medication for sleep disorders.

The Clinical Pathway

A series of clinical trials are set to commence, with a focus on sleep, anxiety, and pain. These trials are a testament to OMG Pharma’s commitment to patient-centered research and development. The insomnia trial, in particular, will be a double-blind, randomized, placebo-controlled study involving 300 patients.

The goal is to assess the efficacy of a sublingual CBD tablet in treating insomnia, with doses ranging from 75mg to the maximum allowed under current regulations.

FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

Lars Beckers

Lars Beckers is a distinguished senior content writer at MMJ Gazette, bringing a wealth of experience and expertise to the realm of medical marijuana and cannabis-related content. With a deep understanding of the industry and a passion for sharing knowledge, Lars's articles offer readers comprehensive insights and engaging narratives in the dynamic world of cannabis. Known for his meticulous research, clarity of expression, and commitment to delivering high-quality content, Lars brings a seasoned perspective to his work, educating and informing audiences on the latest trends and developments in the field.

Iowa’s Legislative Leap: Stricter Hemp Product Regulations and Expanded Medical Cannabis Access
Cannabis Raid in Oakland Yields $10M in Illicit Products, Authorities Say
Related posts
  • Related posts
  • More from author
Marijuana

South Dakota Marijuana Industry Rallies Behind Crackdown on Hemp THC

August 23, 20250
Marijuana

Florida Court Says Medical Marijuana Patients Can Own Guns

August 22, 20250
Cannabis

Los Angeles Greenlighted Massive Fee Hikes for Cannabis Operators—And Businesses Say It Could Break Them

August 7, 20250
Load more
Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

SEARCH
PROMOTIONS
RECENT POSTS
  • South Dakota Marijuana Industry Rallies Behind Crackdown on Hemp THC
  • Florida Court Says Medical Marijuana Patients Can Own Guns
  • Los Angeles Greenlighted Massive Fee Hikes for Cannabis Operators—And Businesses Say It Could Break Them
  • Ayr Wellness to Shutter Grow Sites in Massachusetts and Nevada Amid Financial Strain
  • Cannabis Businesses Face Tightrope Act as Rules Shift State to State
  • Cannabis Dispensaries Rethink Retail: Design That Sells, Not Just Serves
  • Legal Weed’s Tax Nightmare: How Cannabis Firms Are Pushing Back Against 280E
  • Kentucky Gears Up for First Legal Medical Marijuana Sales by Autumn
  • Hemp THC Ban Pulled from Senate Bill After McConnell–Paul Face-Off
  • Oklahoma’s Marijuana Legalisation Fight Is Back—And It’s Getting Personal
    © MMJ Gazette. 2024
    • About
    • Contact Us
    • Privacy Policy
    • Terms and Conditions
    • Authors